Core Viewpoint - The establishment of a joint venture by Global Medical (02666) aims to leverage favorable policies in the Hainan Boao Lecheng International Medical Tourism Pilot Zone to expedite the registration, clinical application, and commercialization of international innovative medical devices in China [1][2] Group 1: Joint Venture Details - The joint venture agreement was signed on November 18, 2025, involving Global Medical, China Machinery New Energy (a wholly-owned subsidiary of the General Technology Group), and Hele Technology [1] - The registered capital of the joint venture is set at RMB 30 million, with contributions from the parties as follows: Global Medical will contribute RMB 15.03 million, China Machinery New Energy will contribute RMB 4.47 million, and Hele Technology will contribute RMB 10.5 million [1] - After the establishment, the ownership structure will be 50.1% for Global Medical, 14.9% for China Machinery New Energy, and 35% for Hele Technology, making the joint venture a subsidiary of Global Medical [1] Group 2: Strategic Objectives - The joint venture aims to utilize the rapid approval channels for urgently needed imported medical devices under the "National Nine Articles" framework, as well as pilot programs for real-world data applications and facilitation for foreign physicians [2] - By collaborating with management agencies, medical institutions, and industry partners, the joint venture will create a platform that integrates policy alignment, technology transfer, and clinical validation [2] - This initiative aligns with national strategies encouraging medical innovation and high-level openness, enhancing the medical device business pipeline of the company and creating long-term value for shareholders [2]
环球医疗拟出资1503万元成立合资公司 将构建集政策对接、技术转化与临床验证于一体的协同平台